In Vivo is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Arbor Pharmaceuticals Inc.

www.arborpharma.com

Latest From Arbor Pharmaceuticals Inc.

Edge 'Devastated' By Phase III Failure of EG-1962, Set To Downsize

Company announces plans for layoffs after Phase III NEWTON 2 study of EG-1962 for subarachnoid hemorrhage goes up in smoke.

Clinical Trials Research & Development

US FDA Learns 'Lessons Of History,' Takes Opioid Fight To Gabapentinoids

Agency investigating potential misuse and abuse of gabapentinoids, which CDC had recommended as alternative to opioids, in latest twist to epidemic.
Neurology Regulation

Medicare Opioid Abuse Prevention Measures To Be Enhanced In 2019

Part D plans would need expanded point-of-sale 'edits' for high-dose prescriptions and supply limits for patients new to opioids under proposal in 2019 'call letter' for the Medicare pharmacy benefit.
Medicare Neurology

Steady M&A Flow Lifts Fosun

Continuing with its dual strategy driven by innovation and internationalization, Fosun Pharmaceutical recently announced two acquisitions on the trot. The deals separately tap into growth opportunities in new biologic products and build on Fosun’s presence in Africa.

BioPharmaceutical China
See All

Company Information

  • Industry
  • Pharmaceuticals
    • Specialty Pharmaceuticals
  • Therapeutic Areas
  • Non-Specific
  • Alias(es)
  • Ownership
  • Private
  • Headquarters
  • Worldwide
    • North America
      • USA
  • Parent & Subsidiaries
  • Arbor Pharmaceuticals Inc.
  • Senior Management
  • Edward Schutter, Pres. & CEO
    Jason McCarthy, CFO
    Brian Adams, PhD, VP, Bus. Dev.
    Steven Caras, MD, PhD, VP, Clinical Dev.
    Thom Rowland, VP, Commercial Ops.
  • Contact Info
  • Arbor Pharmaceuticals Inc.
    Phone: (678) 334-2420
    Six Concourse Pkwy.
    Ste. 1800
    Atlanta, GA 30328
    USA
Advertisement
Advertisement
UsernamePublicRestriction

Register